ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
4
views
0
references
Top references
cited by
25
Cite as...
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,196
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Favourable and sustained response to anakinra in tumour necrosis factor receptor-associated periodic syndrome (TRAPS) with or without AA amyloidosis.
Author(s):
Silvana Chicca
,
Laura Obici
,
Marco Cattalini
,
Simona Donadei
,
Giampaolo Merlini
,
Antonella Meini
,
Marco Galliani
,
Alessandro Plebani
Publication date:
2011-07-31
Journal:
Annals of the Rheumatic Diseases
Keywords:
Adult
,
Amyloidosis
,
drug therapy
,
Antirheumatic Agents
,
therapeutic use
,
Familial Mediterranean Fever
,
Female
,
Follow-Up Studies
,
Humans
,
Interleukin 1 Receptor Antagonist Protein
,
Male
,
Middle Aged
,
Mutation
,
Receptors, Tumor Necrosis Factor
,
genetics
,
Treatment Outcome
,
Young Adult
Read this article at
ScienceOpen
Publisher
PubMed
Review
Review article
Invite someone to review
Bookmark
Cite as...
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Plant MYBs
Author and article information
Journal
PubMed ID::
21173015
DOI::
10.1136/ard.2010.143438
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Amyloidosis
,
drug therapy
,
Antirheumatic Agents
,
therapeutic use
,
Familial Mediterranean Fever
,
Female
,
Follow-Up Studies
,
Humans
,
Interleukin 1 Receptor Antagonist Protein
,
Male
,
Middle Aged
,
Mutation
,
Receptors, Tumor Necrosis Factor
,
genetics
,
Treatment Outcome
,
Young Adult
Data availability:
ScienceOpen disciplines:
Chemistry
Keywords:
Adult
,
Amyloidosis
,
drug therapy
,
Antirheumatic Agents
,
therapeutic use
,
Familial Mediterranean Fever
,
Female
,
Follow-Up Studies
,
Humans
,
Interleukin 1 Receptor Antagonist Protein
,
Male
,
Middle Aged
,
Mutation
,
Receptors, Tumor Necrosis Factor
,
genetics
,
Treatment Outcome
,
Young Adult
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,196
Inhibitory effect of propolis on the development of AA amyloidosis
Authors:
Daichi Harata
,
Yuya Tsuchiya
,
Tomoyuki Miyoshi
…
Increased Hepatic PDGF-AA Signaling Mediates Liver Insulin Resistance in Obesity-Associated Type 2 Diabetes
Authors:
Amar Abderrahmani
,
Loic Yengo
,
Robert Caïazzo
…
Short-term glucocorticoids reduce risk of chronic NSAID and analgesic use in early methotrexate-treated rheumatoid arthritis patients with favourable prognosis: subanalysis of the CareRA randomised controlled trial
Authors:
Sofia Pazmino
,
Annelies Boonen
,
Diederik de Cock
…
See all similar
Cited by
25
ER stress activates the NLRP3 inflammasome via an UPR-independent pathway
Authors:
P Menu
,
A Mayor
,
Michael Zhou
…
Biologics for Targeting Inflammatory Cytokines, Clinical Uses, and Limitations
Authors:
Peleg Rider
,
Yaron Carmi
,
Idan Cohen
Canakinumab treatment for patients with active recurrent or chronic TNF receptor-associated periodic syndrome (TRAPS): an open-label, phase II study
Authors:
Marco Gattorno
,
Laura Obici
,
Marco Cattalini
…
See all cited by